Key facts
- This page summarizes Daveen Chopra's Form 4 filing for Edwards Lifesciences Corp (EW).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Sep 2026, 19:15.
Daveen Chopra - 11 Sep 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)
- Reporting relationship
- CVP, TMTT, Surgical & IHFM
- Issuer ticker
- EW
- Reported as of
- 11 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Sep 2026, 19:15:12 UTC
- Prior SEC filing
- 26 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- Linda J. Park, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daveen Chopra filed Form 4 for Edwards Lifesciences Corp (EW) on 11 Sep 2026.
Change
- Previous filing in this sequence was filed on 26 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001740963
Primary reporting owner
Chopra Daveen
- Relationship
- CVP, TMTT, Surgical & IHFM
- Address
- ONE EDWARDS WAY, IRVINE
- Signature
- Linda J. Park, Attorney-in-Fact
- Signature date
- 11 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EW
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -398
- Change %
- -0.9%
- Price
- $86.77*
- Shares after
- 43,926
- Date
- 11 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
SEC remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.